CHINA CINDA
01359
CHINA SHENHUA
01088
CHINA COAL
01898
GUANGDONG INV
00270
KB LAMINATES
01888
【Brokerage Focus】The Pacific Securities initially rated Lepu Biopharma (02157) as "Buy", indicating that the ADC pipeline is about to enter a harvest period.
Lepu Bio-B (02157.HK): Commercialization has seen initial results, ADC pipelines have entered the harvest period
Lepu Bio-B (02157.HK) In-depth Research Report: ADC pipelines are rich in IO+ADC leading layout
IPO Preview: Lepu Biotech (2157.HK)
IPO Report: Lepu Biotech (2157.HK)